Document:

Tonix Pharmaceuticals Holding Corp. 10-Q

EXHIBIT 10.01

 

AGREEMENT OF PURCHASE AND SALE

THIS AGREEMENT OF PURCHASE
AND SALE (this “Agreement”) is made as of this 26th day of July, 2021 (the “Effective Date”) by and between
SOUTHERN RESEARCH INSTITUTE, an Alabama non-profit organization, having an address at 2000 Ninth Avenue South, Birmingham, Alabama
35205 (“Seller”) and TONIX PHARMACEUTICALS HOLDING CORP., a Nevada corporation, having an address at 26 Main Street,
Chatham NJ 07928 (collectively with its permitted successors and assigns hereunder, “Purchaser”).

W I T N E S S E T H:

WHEREAS, Seller is the owner
of that certain real property comprising approximately 4.99 acres of land located at 431 Aviation Way, in the City of Frederick, County
of Frederick, State of Maryland and more particularly described on Exhibit A attached hereto and made a part hereof (the “Land”,
and together with the Improvements (as defined below), the “Real Property”);

WHEREAS, Purchaser is willing
to purchase and acquire all of Seller’s right, title and interest in and to the Land, together with all right, title and interest
of Seller, if any, in and to the following: (a) all open or proposed highways, streets, roads, avenues, alleys, easements, strips, gores
and rights of way in, on, across, in front of, contiguous to, abutting or adjoining the Land; (b) any and all buildings, structures,
fixtures and other improvements now or hereafter erected on the Land (“Improvements”); (c) such furniture, equipment and
other assets and inventory used in the operation, maintenance or ownership of the Real Property and such other equipment and assets (the
“Equipment”) more particularly described on Exhibit B attached hereto; (d) all water (including riparian, drilling
and pumping), sewer, development, and other rights or any nature appurtenant to the Land or the Improvements; (e) all permits, licenses,
approvals, authorizations issued by any governmental authority in connection with the Land or the Improvements (as opposed to the Equipment);
(f) all assignable Permits (defined below) as contemplated by Section 5.1(i)(v) below; and (g) any and all operating manuals, plans and
specifications and other intangible property associated with the Land or the Improvements (collectively, the “Other Property”),
and Seller is willing to sell, assign and convey to Purchaser its right, title and interest in and to the Real Property and the Other
Property, each upon and subject to the terms and conditions specified herein.

NOW THEREFORE, in consideration
of the foregoing premises, the mutual promises contained herein, and other good and valuable consideration, the receipt and sufficiency
of which is hereby acknowledged, the parties hereto hereby agree as follows:

Article
I

PURCHASE AND SALE

Section 1.1          
Property. Seller agrees to sell, assign and convey to Purchaser, and Purchaser agrees to purchase, assume and acquire from
Seller, all of Seller’s right, title and interest in and to the Real Property and the Other Property (collectively, the “Property”),
upon and subject to the terms and conditions of this Agreement. All references herein to the Property shall mean both the Property as
a whole and any portion thereof.

     

     

    

Section 1.2          
Purchase Price. In consideration of the sale, assignment and conveyance by Seller to Purchaser of the Property pursuant to
the terms of this Agreement, Purchaser agrees to pay Seller an amount equal to Seventeen Million Five Hundred Thousand and 00/100 Dollars
($17,500,000.00) (the “Purchase Price”), payable in cash at the Closing (as defined in Section 3.1) delivered to Seller by
Purchaser, as increased or decreased by prorations, credits, and adjustments as herein provided.

Section 1.3          
Payment of Purchase Price. Subject to Section 3.4 below, the balance of the Purchase Price shall be paid by Purchaser to Seller
at the Closing by wire transfer of immediately available federal funds to a bank account designated by Seller in writing.

Section 1.4          
Escrow Agent; Deposits.

(a)              
Within two (2) Business Days of the Effective Date, Purchaser shall deposit with First American Title Insurance Company (“Escrow
Agent”), the sum of Seven Hundred Fifty Thousand and 00/100 Dollars ($750,000.00) (together with all interest earned thereon, the
“Deposit”) by wire transfer of immediately available federal funds.

(b)              
Escrow Agent shall hold the Deposit in an interest bearing, federally insured escrow account in accordance with the terms and conditions
of this Agreement to be disbursed as provided in this Agreement.

(c)              
Notwithstanding anything to the contrary provided in this Agreement, in each instance where this Agreement provides that the Deposit
shall be provided or returned to Purchaser, subject to Section 1.5 below, Escrow Agent shall disburse the Deposit to Purchaser save and
except for the amount of $10 thereof which shall be disbursed by Escrow Agent to Seller and retained by Seller as independent consideration
to Seller for Seller’s execution of this Agreement.

Section 1.5          
Escrow Agent.

(a)              
If Seller or Purchaser claims that it is entitled to receive all or any portion of the Deposit pursuant to the terms of this Agreement,
that party shall notify Escrow Agent in writing and shall simultaneously deliver written notice of its claim to the other party. Except
as set forth below, if Escrow Agent does not receive a written objection from or on behalf of the other party within ten (10) days after
receipt of the claiming party’s notice, Escrow Agent shall deliver to the claiming party all or that portion of the Deposit claimed
by the claiming party. If Escrow Agent receives conflicting instructions or claims from Seller and Purchaser, Escrow Agent shall continue
to hold the Deposit until jointly directed by Seller and Purchaser or until otherwise directed by a court of competent jurisdiction.
Notwithstanding the foregoing, Escrow Agent shall rely upon and follow the sole instruction of Purchaser in the event Purchaser requests
the Deposit upon a termination pursuant to Sections 2.1, 2.2 or 7.2 of this Agreement. Escrow Agent may at any time discharge its duties
hereunder by depositing the Deposit with a court of competent jurisdiction and notifying Seller and Purchaser.

    -2- 

     

    

(b)              
 The parties acknowledge that Escrow Agent is holding the Deposit solely as a stakeholder at their request and for their convenience,
that Escrow Agent shall not be deemed to be the agent of either party in carrying out its role as escrow agent hereunder, and that Escrow
Agent shall not be liable to either party for any act or omission on its part unless taken in willful disregard of this Agreement or
involving its gross negligence or willful misconduct. Seller and Purchaser jointly and severally indemnify and hold Escrow Agent harmless
from and against any and all claims, liabilities and out-of-pocket expenses (including reasonable out-of-pocket attorneys’ fees
and disbursements and court costs) which Escrow Agent may incur in connection with the performance of its duties hereunder, except with
respect to actions or omissions taken by Escrow Agent in willful disregard of this Agreement or involving Escrow Agent’s gross
negligence or willful misconduct.

(c)              
Escrow Agent has acknowledged its agreement to act as escrow agent in accordance with this Agreement by signing in the place indicated
on the signature page of this Agreement.

(d)              
Since the Deposit will be held in an interest bearing escrow account, Seller and Purchaser each agree to deliver to Escrow Agent a IRS
Form W-9 upon the execution and delivery of this Agreement. All interest earned on the Deposit shall be deemed to have been earned by
the party to whom such interest is received pursuant to this Agreement.

Article
II

TITLE, SURVEY, DUE DILIGENCE and APPROVALS

Section 2.1          
Condition of Title.

(a)              
Purchaser may elect to order, at its sole cost and expense (i) a survey of the Real Property by a licensed surveyor or registered professional
engineer selected by Purchaser (“Survey”); and (ii) a commitment for a policy of title insurance (“Title Commitment”)
issued by Escrow Agent or another nationally recognized title insurance company (“Title Company”) which shall include a schedule
of all title exceptions (and include copies of all recorded title exceptions as shown in the Title Commitment) (the “Title Exceptions”).
Purchaser shall promptly forward copies of the Survey and Title Commitment to Seller and its counsel upon receipt. As used herein, the
term “Title and Survey Objection” shall mean any lien or title defect, exception or matter regarding the Real Property which
is unacceptable to Purchaser as indicated by Purchaser in a written notice provided to Seller in accordance with this Section 2.1.

(b)              
Prior to the end of the Inspection Period (as defined in Section 2.2), Purchaser shall deliver to Seller and Escrow Agent written notice
of any and all Title and Survey Objections that it may have. Subject to the provisions of Section 2.1(c), if Purchaser does not deliver
a written notice to Seller and Escrow Agent of its Title and Survey Objection to any particular lien, title defect, exception or matter
regarding the Real Property that is revealed or disclosed to Purchaser via the Title Commitment or the Survey by such date and time,
then Purchaser shall be deemed to have waived its right to object to such lien, title defect, exception or other matters regarding the
Real Property, and all such matters shall be deemed accepted by Purchaser in their “AS IS” condition.

    -3- 

     

    

(c)              
Prior to the Closing Date (as defined in Section 3.1), Purchaser shall have the right to order an update or a date-down of the Title
Commitment and/or the Survey, and shall have the right, by sending a written notice to Seller and Escrow Agent not later than ten (10)
days after Purchaser receives such update or date-down, but in all events prior to the Closing Date, to make any objections to any lien,
title defect, exception or other title or survey matter regarding the Real Property (a “New Matter Objection”) which is (i)
first revealed or disclosed to Purchaser on such update or date-down (i.e., it was not revealed or disclosed in the Title Commitment
or the Survey); provided, however, that Purchaser shall not have the right to make a New Matter Objection on the basis of any of the
following: (1) any lien, defect, exception or other matter revealed or disclosed to Purchaser via the Title Commitment or the Survey
prior to the end of the Inspection Period); (2) any lien or other matter created or caused by Purchaser or its agents, employees, contractors,
subcontractors, consultants or other representatives (“Purchaser’s Representatives”); and (3) the lien of real property
taxes and assessments not yet due and payable. If Purchaser does not deliver a written notice to Seller and Escrow Agent of its New Matter
Objection to any particular lien, title defect, exception or matter regarding the Real Property by not later than ten (10) days after
Purchaser receives an applicable update or date-down of the Title Commitment and/or the Survey, but in all events prior to the Closing
Date, then Purchaser shall be deemed to have waived its right to object to such matter.

After its timely receipt
of a notice specifying Title and Survey Objections or New Matter Objections, as the case may be (each, an “Objection” and
collectively, the “Objections”), Seller shall have the option, in its sole and absolute discretion, and at its sole cost
and expense, to remedy and remove any Objections and render the title marketable and insurable at regular rates at or prior to the Closing.
Notwithstanding the foregoing, Seller shall be required to satisfy or remove and cause to be released or discharged of record at the
Closing the following liens against the Property: (i) the lien of any mortgage, security agreement, financing statement or other instrument
which evidences or secures indebtedness, that was voluntarily recorded against the Real Property by, at the direction of, or with the
consent of Seller; (ii) mechanic’s liens (excluding liens relating to work or materials commissioned by Purchaser or any of Purchaser’s
Representatives), judgment liens against Seller and real estate tax and assessment liens; (iii) liens which were created, consented to
or permitted by Seller following the Effective Date without the approval of Purchaser as provided in Section 8.22(a); and (iv) any other
liens which have been filed against the Property and reduced to a liquidated sum (excluding any such liens filed by or against Purchaser
or any of Purchaser’s Representatives) (“Required Removal Exceptions”). Within ten (10) Business Days after Seller’s
timely receipt of Purchaser’s notice describing any Objections, Seller shall notify Purchaser in writing as to whether or not Seller
elects to remedy and remove any of such Objections (other than the Required Removal Exceptions, which Seller shall be required to remedy
and remove). However, if Seller fails to so notify Purchaser in writing within the aforementioned allotted time, Seller shall be deemed
to have elected to not remedy and remove such Objections. If Seller agrees in writing to remedy and remove any Objections, then Seller
shall remedy and remove such Objections prior to the Closing, subject to applicable adjournment rights provided herein. If Seller elects,
or is deemed to have elected, to not remedy and remove any Objections, Purchaser shall notify Seller and Escrow Agent in writing within
ten (10) days

    -4- 

     

    

after Purchaser’s receipt of Seller’s
notice electing to not remedy such Objections (or, if applicable, within ten (10) days after the date that Seller has been deemed to
have elected to not remedy and remove such Objections), whether Purchaser elects to waive such Objections and to proceed to consummate
the Closing (without any abatement or reduction in the Purchase Price) or to terminate this Agreement. If Purchaser fails to so notify
Seller in writing within the aforementioned allotted time, Purchaser shall be deemed to have elected to waive such Objections and to
proceed to consummate the Closing without any abatement or reduction in the Purchase Price. As used herein, the term “Permitted
Exceptions” means all Title Exceptions other than the Objections, unless any such Objections are waived by Buyer, in which case
such items shall be included in the Permitted Exceptions.

 

(d)              
 If Purchaser elects to terminate this Agreement within the aforementioned allotted time, the Deposit shall be returned to Purchaser,
and, upon the return of said sum, this Agreement shall terminate and be of no further force and effect and Seller and Purchaser shall
be discharged of all liability, each to the other hereunder, except those liabilities which explicitly survive a termination of this
Agreement.

(e)              
Seller and Purchaser shall each be entitled to adjourn the Closing Date upon written notice to the other and Escrow Agent in order to
allow for the time periods set forth in this Section 2.1 to run their full course, it being agreed that the Closing Date shall be permitted
to be extended to allow the parties the full time periods to respond to the other’s notice or action under this Section 2.1, but
in no event shall the adjournment exceed thirty (30) days after the scheduled date for Closing unless otherwise agreed to in writing
by both parties.

(f)               
As used in this Agreement, the term “Business Day” shall mean any day other than (i) a Saturday or a Sunday, or (ii) a day
observed as a holiday by the State of Maryland or the federal government.

Section 2.2          
Inspection Period. As used herein, the term “Inspection Period” shall mean the period commencing on the Effective
Date and expiring at 5:00 pm, Eastern Time on the date which is forty five (45) days thereafter.

(a)              
By no later than five (5) business days after the Effective Date, to the extent such documents are in Seller’s possession, custody
or control, Seller shall provide to Purchaser true, correct and complete copies of all of the books, records, files, documents, agreements,
instruments and other materials relevant to the Property as set forth on Exhibit C (collectively, the “Inspection Documents”)
which Seller has in its possession, custody or control and which Seller has not previously provided to Buyer. Purchaser and Purchaser’s
Representatives may review the Inspection Documents and perform such studies, tests or inspections of the Property as Purchaser deems
appropriate in its sole and absolute discretion, and at its sole cost, including, without limitation, zoning and land use investigations,
environmental, soil, groundwater and vapor inspections and engineering and geotechnical inspections of the Real Property (collectively,
the “Studies”). If Purchaser shall intend to carry out any inspections which will involve the physical disturbance of any
portion of the Real Property, Purchaser shall give Seller at least five (5) days’ prior written notice of such intention along
with a summary of the intended actions. In the event this Agreement is terminated prior to Closing, upon Seller’s written request
and provided Seller reimburses Purchaser for Purchaser’s out-of-pocket costs in connection therewith, Purchaser shall provide Seller
with a copy of any third-party-prepared report with respect to any Purchaser-performed studies, tests or inspections of the Property.

    -5- 

     

    

(b)              
Seller agrees to provide Purchaser’s Representatives with reasonable access to the Real Property for the purpose of conducting
the Studies in accordance with the terms of this Agreement, in each instance upon one (1) business day notice and contingent upon the
Seller’s approval due to the nature of the research activity being conducted at the Property at the time of the notice; however,
such approval will not be unreasonably withheld. Further, Purchaser agrees to abide by all security and access protocols of Seller before
accessing the Property. Purchaser agrees to conduct all Studies at Purchaser’s sole cost and expense.

(c)              
Any portions of the Real Property which are materially disturbed or otherwise materially damaged by Purchaser or Purchaser’s Representatives
shall, be promptly restored by Purchaser, at its sole cost and expense, to as near as practicable to their prior existing condition.
Purchaser hereby agrees to protect, defend, indemnify and hold Seller and its members, officers, principals, employees and agents, and
each of the respective affiliates of the foregoing (collectively, “Seller Parties”) harmless from and against any and all
liabilities, claims, losses and damages, demands, judgments and out-of-pocket costs and expenses (including reasonable attorneys’
fees and expenses) which Seller or any of Seller Parties incur as a result of physical damage to the Real Property or injury to persons
on the Real Property which were determined by a final order of a court of competent jurisdiction to have been caused by, or to have resulted
from, the conduct of the Studies or any other entry onto the Real Property by Purchaser or Purchaser’s Representatives; provided,
however, that Purchaser shall not be responsible for any of the foregoing which may result from any pre-existing condition or defect
in the Real Property, such as the presence, or exacerbation of, any hazardous substance. The foregoing indemnity and hold harmless obligation
shall survive the Closing or the termination of this Agreement.

(d)              
If, during the Inspection Period, Purchaser determines in its sole discretion, for any reason or for no reason
at all, that the Property is not satisfactory for Purchaser’s purposes, Purchaser may elect to terminate this Agreement by delivering
its written notice of termination to Seller and Escrow Agent prior to the expiration of the Inspection Period.
Upon such termination, Purchaser shall be entitled to the return of the Deposit,
following the return of which sum this Agreement shall terminate and be of no further force and effect and Seller and Purchaser shall
be discharged of all liability, each to the other hereunder, except those liabilities which explicitly survive the
termination of this Agreement.

Article
III

CLOSING

Section 3.1          
Closing of Title. Provided that all contingencies to the consummation of the Closing which are expressly specified herein
shall have been satisfied or waived, the consummation of the transactions contemplated hereby (the “Closing”) shall be conducted
and completed via mail in escrow between counsel for Seller and Purchaser and Escrow Agent on October 1, 2021 (subject to the express
adjournment rights herein, the “Closing Date”).

    -6- 

     

    

Section 3.2          
Seller’s Obligations at the Closing. In connection with the Closing, Seller shall deliver to Purchaser:

(a)              
possession of the Property, together with all keys that are in Seller’s possession, security codes, passwords and combinations
to the Property, if any;

(b)              
a duly executed and acknowledged general warranty deed conveying good and marketable fee simple title to the Land in the form attached
hereto as Exhibit D (the “Deed”) subject to the Permitted Exceptions;

(c)              
all tax declaration forms associated with any applicable Maryland documentary stamp taxes, City conveyance taxes and any other stamp,
transfer or conveyance taxes associated with the recordation of the Deed and/or the payment of the Purchase Price;

(d)              
a duly executed affidavit of title reasonably acceptable to the Title Company;

(e)              
a duly executed omnibus bill of sale, assignment and assumption agreement in the form attached hereto as Exhibit E effecting the
sale and assignment of all of the Other Property (the “Omnibus Assignment”);

(f)               
evidence of the existence, organization, good standing and authority of Seller and the authority of the person(s) executing documents
on behalf of Seller reasonably satisfactory to Title Company and Purchaser;

(g)              
a duly executed certification that Seller is not a “foreign person” for purposes of Section 1445 of the Internal Revenue
Code of 1986, as amended, in the form attached hereto as Exhibit F;

(h)              
a duly executed certification of exemption from withholding from Seller in accordance with Md. Tax-General Code Ann. §10-912;

(i)                
a duly executed certificate from Seller which confirms that Seller’s representations and warranties set forth herein are true and
correct in all material respects as of the Closing Date except as provided in such certificate (“Seller’s Closing Certificate”);

(j)                
a duly executed closing statement showing the Purchase Price and all credits and prorations thereto in a form mutually agreed by Purchaser
and Seller (the “Closing Statement”). Seller and Purchaser hereby designate Escrow Agent as the “reporting person”
for the transaction pursuant to Section 6045(e) of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder
and agree to execute such reasonable documentation as is reasonably necessary to effectuate such designation; and

(k)              
such other and further documents as may be reasonably required to consummate the sale and purchase contemplated hereby which are not
inconsistent with this Agreement.

    -7- 

     

    

Section 3.3          
Purchaser’s Obligations at the Closing. In connection with the Closing, Purchaser shall deliver to Seller:

(a)              
the balance of the Purchase Price due and payable on the Closing Date, subject to Sections 3.4 and 3.5 below, as well as a direction
to Escrow Agent to comply with Section 3.4 below;

(b)              
a certificate duly executed by Purchaser which confirms that Purchaser’s representations and warranties set forth herein are true
and correct in all material respects as of the Closing Date except as provided in such certificate;

(c)              
the Closing Statement, duly executed by Purchaser;

(d)              
evidence of the existence, organization, good standing and authority of Purchaser and the authority of the person(s) executing documents
on behalf of Purchaser reasonably satisfactory to Seller; and

(e)              
such other and further documents as may be reasonably required to consummate the sale and purchase contemplated hereby which are not
inconsistent with this Agreement.

Section 3.4          
Escrow Agent’s Obligations at the Closing. Provided that all contingencies to the consummation of the Closing which
are expressly specified herein shall have been satisfied or waived, on the Closing Date, Seller and Purchaser shall jointly direct Escrow
Agent to disburse the Deposit to Seller in payment of a portion of the Purchase Price. Escrow Agent agrees that it shall follow such
joint direction in accordance with its terms.

Section 3.5          
Credits and Prorations.

(a)              
Real estate taxes and assessments levied against the Real Property as well as sewer charges, water rents, assessments, and all other
items typically adjusted upon the sale of commercial real estate in Frederick County, Maryland, shall be apportioned with respect to
the Real Property as of 12:01 a.m. on the Closing Date, as if Purchaser were vested with title to the Real Property during the entire
day upon which the Closing occurs; provided, however, that with respect to real estate taxes (i) if there are any tax appeals pending
as of the Closing Date, all amounts credited to the Real Property or otherwise received as a result thereof, together with interest thereon,
shall be payable to Seller, except as to the year in which the Closing shall occur, any amounts credited to the Real Property or otherwise
received as a result thereof shall be apportioned between Seller and Purchaser as of the Closing Date on a pro-rata basis after the deduction
of all out-of-pocket costs of recovery (including reasonable out-of-pocket attorneys’ fees and costs) and Seller’s portion
thereof (together with all out-of-pocket costs of recovery, including reasonable attorneys’ fees and costs) shall be payable to
Seller and (ii) all assessments for public improvements which have been physically completed as of the Closing Date are to be paid by
Seller in full in connection with the Closing from the proceeds of the Purchase Price.

(b)              
On the Closing Date, in connection with the consummation of the Closing, at Purchaser’s request, Seller will assign to Purchaser
any deposits that Seller maintains with utility companies applicable to the Real Property. In the event of any such assignment, the amount
of any such deposit shall be paid to Seller by Purchaser on the Closing Date separate and apart from the Purchase Price.

    -8- 

     

    

(c)              
Seller shall be entitled to continue or decline, at its option, to prosecute any tax appeals which may be pending as of the Closing Date,
however, Seller shall take no action to appeal, forego appeal, settle or compromise taxes for the tax year in which the Closing shall
occur without the reasonable approval of Purchaser.

(d)              
Seller and Purchaser agree to cooperate with one another in good faith for a period of one (1) year following the Closing to correct
any errors in credits or prorations in connection with the Closing and to “true-up” any prorations which were estimated as
of the Closing. In connection with the foregoing, Seller and Purchaser agree to promptly pay to the party entitled thereto any refund,
credit or other payment necessary to correct such errors or affect such "true-up".

(e)              
The provisions of this Section 3.5 shall survive the Closing.

Section 3.6          
Closing Costs.

(a)              
Seller shall pay (i) the fees of any counsel representing Seller in connection with this Agreement and the transactions contemplated
hereby, and (ii) all recording charges pertaining to the removal of any mortgages, liens, exceptions or encumbrances in accordance with
Section 2.1.

(b)              
Purchaser shall pay (i) the fees of any counsel representing Purchaser in connection with this Agreement and the transactions contemplated
hereby, (ii) the fees, costs and expenses of any title examinations prepared by Title Company, (iii) the fees and costs, if any, related
to any surveys, inspections and other reports commissioned by Purchaser in connection with the Studies and the transactions contemplated
by this Agreement, (iv) all recording charges pertaining to the recording of the Deed, and (v) all title insurance premiums and costs.

(c)              
The Parties shall equally divide any documentary stamp taxes, city or county conveyance taxes and any other stamp, transfer or conveyance
taxes imposed by the State of Maryland, the County of Frederick, the City of Frederick or any other governmental authorities in connection
with the payment of the Purchase Price in connection with the transactions contemplated at the Closing.

(d)              
All other costs and expenses incident to the transactions contemplated hereby and the Closing shall be paid by the party incurring same.

Section 3.7          
Conditions Precedent to Obligation of Purchaser to Consummate the Closing. The obligation of Purchaser to consummate the Closing
shall be subject to the fulfillment, satisfaction or waiver by Purchaser of the following conditions (it being understood that Purchaser
shall be deemed to have waived any of the following conditions which are unfulfilled as of the Closing Date if Purchaser decides to consummate
the Closing despite such condition being unfulfilled, except to the extent of the survival of representations and warranties set forth
herein):

    -9- 

     

    

(a)              
 Seller shall have performed and observed, in all material respects, all covenants and agreements of this Agreement to be performed and
observed by Seller;

(b)              
All representations and warranties of Seller set forth herein shall be true and correct in all material respects as of the Closing Date
as if made on the Closing Date;

(c)              
No material change shall have occurred in the condition of the Property since the expiration of the Inspection Period and no litigation
shall have been commenced since the Effective Date which, if adversely determined, could reasonably be expected to have a material adverse
impact on the Property; and

(d)              
Seller has obtained the Seller Approvals (hereinafter defined).

(e)              
Purchaser has obtained all licenses, permits, consents, approvals or similar authorizations necessary to acquire at Closing and operate
thereafter the Cesium Irradiator (and all equipment and property related thereto) located in the Improvements.

In the event that any of
the foregoing conditions precedent shall not have been satisfied by the Closing Date, Purchaser may terminate this Agreement upon written
notice to Seller and Escrow Agent, whereupon Escrow Agent shall promptly return the Deposit to Purchaser. Further, in the event of a
termination of this Agreement in connection with the condition precedent in Section 3.7(d) having not been satisfied, Purchaser shall
also be immediately entitled to receive upon written demand payment from Seller to reimburse Purchaser for all actual, reasonable out-of-pocket
costs incurred by Purchaser in connection with the purchase and sale transaction contemplated by this Agreement, including, without limitation,
costs associated with Purchaser’s negotiation of this Agreement (including, without limitation, all expenses) and its performance
of the Studies (“Purchaser’s Reimbursable Costs”) in an amount not to exceed $250,000.00 (“Purchaser’s
Reimbursable Costs Cap”). Following such termination and the return of the Deposit and Purchaser’s Reimbursable Costs, if
applicable, this Agreement shall terminate and be of no further force and effect except for any provisions hereof which shall survive
a termination. However, nothing in the foregoing is intended to deprive Purchaser of its right to exercise its rights and remedies under
Article VI if a failure of any of the foregoing conditions precedent to be satisfied is the result of a breach or default of this Agreement
by Seller or its representatives, or limit Seller’s obligations pursuant to Section 3.8 below.

Section 3.8          
Conditions Precedent to Obligation of Seller to Consummate the Closing. The obligation of Seller to consummate the Closing
shall be subject to the fulfillment, satisfaction or waiver by Seller of the following conditions (it being understood that Seller shall
be deemed to have waived any of the following conditions which are unfulfilled as of the Closing Date if Seller decides to consummate
the Closing despite such condition being unfulfilled, except to the extent of the survival of representations and warranties set forth
herein):

(a)              
Purchaser shall have performed and observed, in all material respects, all covenants and agreements of this Agreement to be performed
and observed by Purchaser;

(b)              
Seller has obtained the written approval of (i) the Board of Directors of Seller and (ii) any judicial or quasi-judicial regulatory body,
including all applicable Municipal, County and State authorities, who may have jurisdiction over the transfer of any assignable Permit
(as contemplated in Section 5.1(i)(v) below) or any aspect of the transactions contemplated herein, to enter into the transactions contemplated
herein (collectively, the “Seller Approvals”); and

    -10- 

     

    

(c)              
All representations and warranties of Purchaser set forth herein shall be true and correct in all material respects as of the Closing
Date as if made on the Closing Date.

In the event that any of
the foregoing conditions precedent shall not have been satisfied by the Closing Date, Seller may terminate this Agreement upon written
notice to Purchaser and Escrow Agent, whereupon Escrow Agent shall promptly return the Deposit to Purchaser. Further, as a condition
of Seller’s termination of this Agreement in connection with the condition precedent in Section 3.8(b) having not been satisfied,
Purchaser shall also be immediately entitled to receive upon written demand payment from Seller to reimburse Purchaser for Purchaser’s
Reimbursable Costs in an amount not to exceed Purchaser’s Reimbursable Costs Cap. Following any such termination and the return
of the Deposit and payment of Purchaser’s Reimbursable Costs, if applicable, this Agreement shall terminate and be of no further
force and effect except for any provisions hereof which shall survive a termination. However, nothing in the foregoing is intended to
deprive Seller of its right to exercise its rights and remedies under Article VI if a failure of any of the foregoing conditions precedent
to be satisfied is the result of a breach or default of this Agreement by Purchaser or its representatives.

Article
IV

SELLER COVENANTS

Section 4.1          
Covenants of Seller.

(a)              
Between the Effective Date and the Closing Date, Seller shall not knowingly cause any easements, restrictions, liens or other encumbrances
to be filed or recorded against the Real Property by or through its actions without Purchaser’s approval.

(b)              
Between the Effective Date and the Closing Date, Seller shall operate and maintain the Property in a manner consistent with Seller’s
past practices.

(c)              
Between the Effective Date and the Closing Date, Seller shall not enter into or otherwise modify any lease, license, agreement or contract
of any nature that is or will be binding on the Property or that would be binding on Purchaser following the Closing without Purchaser’s
approval.

(d)              
Seller will not cause, consent to or otherwise permit any material adverse change to the Property between the Effective Date and the
Closing Date.

(e)              
Between the Effective Date and the Closing Date, Seller shall maintain and keep in full force and effect all insurance policies concerning
the Property that are in effect as of the Effective Date and such other insurance as would be carried by a reasonably prudent owner of
the Property.

    -11- 

     

    

(f)               
 Seller shall promptly notify Purchaser upon receipt of any notice with respect to or otherwise concerning the Property received from
any governmental organization, agency or authority or any utility company, and provide copies of the same to Purchaser.

(g)              
Between the Effective Date and the Closing Date, Seller shall maintain in full force and effect all Permits (as defined herein).

(h)              
Seller shall use diligent, commercially reasonable best efforts to obtain the Seller’s Approvals on or before the date which is
five (5) Business Days prior to the Closing Date. As soon as practicable following the receipt by Seller of the Seller’s Approvals,
Seller shall immediately (but no later than one (1) Business Day) notify Purchaser in writing that the condition precedent in Section
3.8(b) has been satisfied.

 

Article
V

REPRESENTATIONS AND WARRANTIES

Section 5.1          
Representations and Warranties of Seller. Seller hereby makes the following representations and warranties to Purchaser:

(a)              
Organization and Authority. Seller has been duly organized and is validly existing and in good standing as a non-profit corporation
under the laws of the State of Alabama. Seller has the full right and authority to enter into this Agreement and to transfer the Property
pursuant hereto and to consummate or cause to be consummated the transaction contemplated herein. The person signing this Agreement on
behalf of Seller is authorized to do so. Assuming the due authorization, execution and delivery of this Agreement by and on behalf of
Purchaser, this Agreement constitutes a valid and binding obligation of Seller enforceable against Seller in accordance with its terms,
subject to the effects of bankruptcy, insolvency, reorganization, receivership and other similar laws affecting the rights and remedies
of creditors and principles of equity. Neither the execution and delivery hereof, nor the taking of any of the actions contemplated hereby,
will conflict with or result in a breach of any of the provisions of, or constitute a default, event of default or event creating a right
of acceleration, termination or cancellation under any document, judgment, award, decree or other order of a court of competent jurisdiction
to which Seller is bound.

(b)              
Pending Actions. There are no actions, suits, arbitrations, or other proceedings pending against Seller or the Property or the
transactions contemplated by this Agreement, which, if adversely determined, could individually or in the aggregate have an adverse effect
on the Property, on Seller’s ability to transfer its title to the Property in the manner contemplated herein or which could in
any material way interfere with the consummation by Seller of the transactions contemplated by this Agreement. There are no tax appeals
pending with respect to the Real Property.

    -12- 

     

    

(c)              
Environmental Matters. Seller has received no written notice from any governmental authority, and otherwise Seller has no knowledge,
of the presence on, in, below or about the Real Property of any Hazardous Substance in violation of any applicable Environmental Laws.
As used herein, “Hazardous Substance” means any hazardous, dangerous or toxic materials, substances, pollutants, contaminants,
or wastes currently identified as a hazardous substance or waste (including asbestos or polychlorinated biphenyl) in the Comprehensive
Environmental Response, Compensation and Liability Act of 1980, 42 U.S.C. §§9601, et seq., Solid Waste Disposal Act, 42 U.S.C.
§§6901, et seq., the Superfund Amendments and Reauthorization Act, 40 U.S.C. §§1101, et seq. and the Resource Conservation
and Recovery Act, 42 U.S.C. §§6901, et seq., in each case together with its implementing regulations, guidance and policies
and amendments thereto, and any other federal, state or local statute, law, code, rule, regulation, order, judgment, decree, legislation,
ordinance, equitable doctrine or other requirement of any governmental authority affecting any portion of the Real Property or any Seller
with respect to, pertaining to or otherwise relating to health and safety, the environment, any hazardous, toxic or dangerous waste,
substance or material, including, without limitation, those relating to soil and groundwater conditions (collectively, “Environmental
Laws”).

(d)              
Notice of Violation of Law. Seller has not received any written notice from any federal, state, county or municipal authority
which alleges that the Property is not in compliance with any statute, rule, regulation or ordinance applicable to the Property, and
to Seller’s knowledge, the Property is not in violation of any statue, rule, regulation or ordinance applicable to the Property,
including but not limited to the City of Frederick Land Management Code, Ordinance No G-20-15 (Supp. No. 9)

(e)              
Bankruptcy and Insolvency. Seller is solvent, has not filed any voluntary petition in bankruptcy or been adjudicated as bankrupt
or insolvent, has not been the subject of an involuntary proceeding in bankruptcy which has not been vacated or stayed within thirty
(30) days of the filing of such proceeding, and has not filed any petition or answer seeking any reorganization, liquidation, dissolution
or similar relief under any federal bankruptcy or insolvency laws, or other relief for debtors, and has not sought or consented to or
acquiesced in the appointment of any trustee, receiver, conservator or liquidator of all or any substantial part of its assets or its
interest in any property. No court of competent jurisdiction has entered an order, judgment, or decree approving a reorganization, arrangement,
composition, readjustment, liquidation, dissolution or similar relief under any federal bankruptcy act, and no liquidator of Seller or
of all or any substantial part of its assets or its interest in any property has been appointed. Seller has not admitted in writing or
otherwise alleged to any person or entity that it is insolvent or is suspending or under the pending suspension of its operations.

(f)               
No Leases, Contracts or Agreements. There are no agreements or contracts of any kind, including leases, subleases, licenses or
other occupancy agreements, supply contracts, service contracts or farming agreements (whether acreage or tonnage), which are in effect
with respect to the Real Property that will be binding on Purchaser or the Real Property following the Closing. In addition, Seller has
not entered into any oral leases, rental agreements, licenses, license agreements or other occupancy agreements nor has it entered into
any oral extensions, amendments or modifications to any leases, rental agreements, licenses, license agreements or other occupancy agreements
affecting the Real Property.

(g)              
No Condemnation. Seller has not received written notice of any pending condemnation or eminent domain proceedings affecting the
Real Property.

    -13- 

     

    

(h)              
 Utility Deposits and Rollback Assessments. Seller maintains no deposits with utility companies applicable to the Real Property
and the Real Property is fully assessed for tax purposes and is not subject to any farmland or other reduced assessment that would subject
Purchaser to a rollback assessment after the Closing.

(i)                
Regulatory Matters.

(i)                
Seller and its respective employees and agents hold all permits, certificates, licenses, variances, registrations, exemptions, orders,
consents and approvals (collectively, “Permits”) from the U.S. Food and Drug Administration (the “FDA”) and any
other governmental entity necessary for the lawful operation of the businesses of Seller conducted at the Real Property, including Permits
required under the Federal Food, Drug, and Cosmetic Act for the testing of any chemicals or pharmaceuticals. Exhibit G sets forth
a list of all Permits as of the date of this Agreement. All such Permits are valid, and in full force and effect. There has not occurred
any violation of, default (with or without notice or lapse of time or both) under, or event giving to others any right of termination,
amendment or cancellation of, with or without notice or lapse of time or both, any Permit. Seller is in compliance in all material respects
with the terms of all Permits, and no event has occurred that, would reasonably be expected to result in the revocation, cancellation,
non-renewal or adverse modification of any Permit.

(ii)             
Seller is and has been in compliance in all material respects with all applicable statutes, rules, regulations, decrees, writs and orders
of the FDA and any other regulatory agency with respect to the labeling, storing, testing, development, manufacture, packaging and distribution
of Seller products used at the Real Property. No investigation or review by any governmental entity with respect to the Real Property
or any Seller activity related to the Real Property is pending or, to the Knowledge of Seller, threatened, nor has any governmental entity
indicated an intention to conduct the same. All pre-clinical studies conducted by Seller at the Real Property have been and are being
conducted in compliance in all material respects with applicable Permits, laws, regulations and guidances, including, without limitation,
the applicable requirements of the FDA’s current Good Manufacturing Practices, Good Laboratory Practices, Good Clinical Practices
and other applicable requirements contained in 21 CFR Parts 312, 50, 54, 56 and 11.

(iii)           
In relation to the Real Property, there are no proceedings pending or, to Seller’s Knowledge, threatened with respect to a violation
or alleged violation by Seller of any rules and regulations of any applicable governmental authorities or regulatory bodies (including
without limitation, the FDCA, FDA regulations adopted thereunder, the Controlled Substance Act or any other legislation or regulation
promulgated by any other Seller regulatory agency). All applications, submissions, information and data utilized by any Seller as the
basis for, or submitted by or on behalf of Seller or any of its Subsidiaries in connection with any and all requests for a Permit, when
submitted to the FDA or other Seller regulatory agency, were true, correct and complete in all material respects as of the date of submission,
and any updates, changes, corrections or modification to such applications, submissions, information and data required under applicable
Laws have been submitted to the FDA or other Seller regulatory agency. To the Knowledge of Seller, no data generated by Seller with respect
to products or services related to the Real Property is the subject of any action, either pending or threatened, by any Seller regulatory
agency relating to the truthfulness or scientific adequacy of such data.

    -14- 

     

    

(iv)            
 Seller has made available to Purchaser true, correct and complete copies of any and all Permits and regulatory documents related to
the Property, including documents that indicate or suggest lack of compliance with the regulatory requirements of the FDA or other Seller
regulatory agency.

(v)              
In connection with Closing, at no cost to Purchaser, Seller shall assign or cause to be assigned to Purchaser (or Purchaser’s designee),
to the extent assignable and useable by parties other than Seller, all the Permits. Further, with respect to such Permits which are not
so assignable, Seller agrees to reasonably assist Purchaser in the execution of documents (including, without limitation, applications)
and otherwise to provide commercially reasonable cooperation (as determined in Seller’s reasonable discretion) in such respects,
at no material cost to Seller, as may be requested by Purchaser to enable Purchaser to apply for and obtain such similar permits for
Purchaser’s (or its designee’s) benefit. The provisions of this Section 5.1(i)(v) shall survive the Closing for a period
of six (6) months. .

(j)                
OFAC and Anti-Corruption. Pursuant to United States Presidential Executive Order 13224 (the “Order”), the USA Patriot
Act of 2001 (Public Law 107-56) (“Patriot Act”), the related rules and regulations of the Office of Foreign Assets Control
(“OFAC”) of the U.S. Department of the Treasury, and any enabling laws or other executive orders or regulations in respect
thereof (the Patriot Act, the Order and such other rules, regulations, laws or orders are collectively referred in this Agreement as
the “Anti-Terrorism Laws”), U.S. persons and entities are prohibited from transacting business with persons or entities who,
from time to time are determined to have committed, or to pose a risk of committing or supporting, terrorist acts, narcotics trafficking,
money laundering and related crimes. Those persons and entities are identified on a list of Specially Designated Nationals and Blocked
Persons (the “List”), published and regulated by OFAC. The names, including aliases, of these persons or entities are updated
frequently. In addition, OFAC enforces other Orders which, from time to time, impose restrictions on transactions with, or involving
certain countries. Seller hereby certifies and represents that neither it, nor any of its owners, members of its governing body, management,
employees, parent, subsidiary, affiliate, or agents is on the List or is acting for, or on behalf of, or otherwise associated (as that
term is used in the Order) with, any person or entity on the List. Seller further acknowledges its obligation to remain in compliance
with existing and future regulations promulgated by OFAC throughout the term of this Agreement.

(i)                
Seller represents and warrants that neither it nor its affiliates, nor any of their respective officers, directors, employees or agents
have ever given, promised to give, received or solicited, anything of value, directly or indirectly, to or from any person for the purpose
of inducing any such person, including any government official (domestic or foreign), to take any action to the benefit of Seller in
connection with this Agreement, or as an inducement for Seller to take any action to the benefit of such other person in connection with
this Agreement.

(ii)             
Seller covenants and agrees that it shall not give, promise to give, receive or solicit, anything of value, directly or indirectly, to
or from any person for the purpose of inducing any such person, including any government official (domestic or foreign), to take any
action for the benefit of Seller or its affiliates or their respective officers, directors, employees or agents in connection with this
Agreement, or as an inducement for Seller or its affiliates or their respective officers, directors, employee or agents to take any action
to the benefit of such other person in connection with this Agreement.

    -15- 

     

    

(iii)           
Seller represents and warrants that neither Seller nor any parent, subsidiary or affiliate entity of Seller (i) is listed on the Specially
Designated Nationals and Blocked Persons List maintained by OFAC pursuant to the Order and/or on any other list of terrorists or terrorist
organizations maintained pursuant to any of the rules and regulations of OFAC or pursuant to any of the other Anti-Terrorism Laws, (ii)
is or will become a person or entity listed in or subject to the Order or (iii) knowingly engages or knowingly will engage in any dealings
or transactions, or knowingly is or knowingly will be otherwise associated, with any such person or entity referred to in the foregoing
clauses (i) and/or (ii).

(k)              
CFIUS. The transaction contemplated by this Agreement is not a covered transaction as defined in 31 C.F.R. § 800.213 or a
covered real estate transaction as defined in 31 C.F.R. § 802.212.

 

Section 5.2          
Survival of Seller’s Representations and Warranties. The representations and warranties of Seller set forth in this
Agreement shall survive the Closing for a period limited to twelve months after the Closing (the “Survival Period”), at which
time they shall terminate unless Purchaser has notified Seller in writing of any breach prior to the expiration of the Survival Period
and provided further that the damages from any breach by Seller for which timely notice has been given by Purchaser and which is in an
amount reasonably likely to exceed $50,000.

Section 5.3          
Representations and Warranties of Purchaser. Purchaser hereby makes the following representations and warranties to Seller:

(a)              
Organization and Authority. Purchaser has been duly organized and is validly existing and in good standing as a corporation under
the laws of the State of Nevada. Purchaser has the full right and authority to enter into this Agreement and to acquire the Property
pursuant hereto and to consummate or cause to be consummated the transaction contemplated herein. The person signing this Agreement on
behalf of Purchaser is authorized to do so. Assuming the due authorization, execution and delivery of this Agreement by and on behalf
of Seller, this Agreement constitutes a valid and binding obligation of Purchaser enforceable against Purchaser in accordance with its
terms, subject to the effects of bankruptcy, insolvency, reorganization, receivership and other similar laws affecting the rights and
remedies of creditors and principles of equity. Neither the execution and delivery hereof, nor the taking of any of the actions contemplated
hereby, will conflict with or result in a breach of any of the provisions of, or constitute a default, event of default or event creating
a right of acceleration, termination or cancellation under the organizational documents of Purchaser or under any instrument, note, mortgage,
contract, judgment, order, award, decree or other agreement to which Purchaser is a party, or by which Purchaser is otherwise bound.

(b)              
Pending Actions. There is no action, suit, arbitration, unsatisfied order or judgment, government investigation or proceeding
pending against Purchaser which, if adversely determined, could individually or in the aggregate materially interfere with the consummation
by Purchaser of the transaction contemplated by this Agreement.

    -16- 

     

    

(c)              
 Bankruptcy and Insolvency. Purchaser is solvent, has the financial capacity to fulfill its obligations hereunder, has not filed
any voluntary petition in bankruptcy or been adjudicated as bankrupt or insolvent, has not been the subject of an involuntary proceeding
in bankruptcy which has not been vacated or stayed within thirty (30) days of the filing of such proceeding, and has not filed any petition
or answer seeking any reorganization, liquidation, dissolution or similar relief under any federal bankruptcy or insolvency laws, or
other relief for debtors, and has not sought or consented to or acquiesced in the appointment of any trustee, receiver, conservator or
liquidator of all or any substantial part of its assets or its interest in any property. No court of competent jurisdiction has entered
an order, judgment, or decree approving a reorganization, arrangement, composition, readjustment, liquidation, dissolution or similar
relief under any federal bankruptcy act, and no liquidator of Purchaser or of all or any substantial part of its assets or its interest
in any property has been appointed. Purchaser has not admitted in writing or otherwise alleged to any person or entity that it is insolvent
or is suspending or under the pending suspension of its operations.

(d)              
Patriot Act Compliance. Neither Purchaser nor any parent, subsidiary or affiliate entity of Purchaser
(i) is listed on the Specially Designated Nationals and Blocked Persons List maintained by OFAC pursuant to the Order and/or on any other
list of terrorists or terrorist organizations maintained pursuant to any of the rules and regulations of OFAC or pursuant to any of the
other Anti-Terrorism Laws, (ii) is or will become a person or entity listed in or subject to the Order or (iii) knowingly engages or
knowingly will engage in any dealings or transactions, or knowingly is or knowingly will be otherwise associated, with any such person
or entity referred to in the foregoing clauses (i) and/or (ii). No portion of the Purchase Price has been or will be derived by Purchaser
in violation of any of the Anti-Terrorism Laws or from any other person or entity described in the foregoing sentence. The
Purchaser is not considered a “foreign person,” as that term is defined in 31 C.F.R. § 800.224.

Section 5.4          
Survival of Purchaser’s Representations and Warranties. The representations and warranties of Purchaser set forth in
Section 5.3 above shall survive the Closing for a period limited to twelve months after the Closing.

Article
VI

DEFAULT AND REMEDIES

Section 6.1          
Seller’s Remedies for Purchaser’s Default at or prior to the Closing. If (a) Purchaser fails to perform
any of its obligations under this Agreement at or prior to the consummation of the Closing for any reason except failure by Seller to
perform hereunder or failure of an express condition precedent to Purchaser’s obligation to consummate the Closing as set forth
in Section 3.7 (and thereafter fails to remedy such default within ten (10) days after Seller’s written notice to Purchaser specifying
such default, during which period Purchaser shall diligently pursue such remedy), or (b) on or prior to the Closing Date any one or more
of Purchaser’s representations or warranties are discovered by Seller to have been breached in any material respect, Seller shall
be entitled, as its sole and exclusive remedy (except as provided in Section 6.3(a) and (b) below), to
terminate this Agreement UPON WRITTEN NOTICE TO PURCHASER AND ESCROW AGENT and receive and retain the DEPOSIT as liquidated damages for
the DEFAULT BY PURCHASER UNDER this Agreement; it being expressly agreed between the parties hereto that the actual damages to Seller
in the event of such breach are DIFFICULT AND impractical, IF NOT IMPOSSIBLE, to ascertain and the amount of the DEPOSIT is a fair and
reasonable estimate thereof. Upon such termination and receipt of the Deposit, this Agreement shall be terminated and neither party shall
have any further liability to the other except to the extent of any obligations which expressly survive a termination and except as provided
in Section 6.3 below.

    -17- 

     

    

Section 6.2          
Purchaser’s Remedies for Seller’s Default at or prior to the Closing. If (a) Seller fails to perform its obligations
under this Agreement for any reason except failure by Purchaser to perform hereunder or failure of an express condition precedent to
Seller’s obligation to consummate the Closing as set forth in Section 3.8 (and thereafter fails to remedy such default within ten
(10) days after Purchaser’s written notice to Seller specifying such default, during which period Seller shall diligently pursue
such remedy), or (b) on or prior to the consummation of the Closing any one or more of Seller’s representations or warranties are
discovered by Purchaser to have been breached in any material respect, Purchaser shall be entitled, as its sole and exclusive remedy
in such event (except as provided in Section 6.3 below), either to (x) terminate this Agreement upon written notice to Seller and Escrow
Agent and receive the Deposit, or (y) seek specific performance of this Agreement by Seller (and any costs or expenses incurred by Purchaser
in seeking specific performance shall be credited against the Purchase Price at Closing). Notwithstanding anything herein to the contrary,
if (i) the remedy of specific performance is not available due to the nature of Seller’s default, or (ii) Seller has fraudulently
and willfully caused a material misrepresentation of an express representation or warranty of Seller in this Agreement, or (iii) Purchaser
terminates under this Section 6.2 prior to the satisfaction of the condition precedent described in Section 3.7(d) above, then Seller
shall also reimburse Purchaser for Purchaser’s Reimbursable Costs in an amount not to exceed Purchaser’s Reimbursable Costs
Cap. In the event Purchaser seeks specific performance in accordance
with this Section 6.2, Purchaser shall have the right to injunctive or other equitable relief of its rights under this Agreement, in
addition to any and all other rights and remedies at law or in equity, and all such rights and remedies shall be cumulative. The parties
agree that the remedies at law for any breach or threatened breach, including monetary damages, may be inadequate compensation for any
loss and that any defense in any action for specific performance that a remedy at law would be adequate is waived. Upon any termination
and receipt of Purchaser’s Reimbursable Costs, if applicable, and the Deposit pursuant to this Section 6.2, this Agreement shall
terminate and neither party shall have any further liability to the other except to the extent of any obligations which expressly survive
a termination and except as provided herein and in Section 6.3 below.

Section 6.3          
Additional Special Remedies. Notwithstanding anything in this Article VI to the contrary:

(a)              
Seller and Purchaser shall be entitled to strictly enforce the indemnities provided herein. Further, the limitations on the enforcement
of remedies provided in this Article VI shall not affect or otherwise limit the right of Seller or Purchaser to enforce any remedy at
law or in equity in the event of the breach of an obligation of the other party hereunder which expressly survives the Closing or sooner
termination of this Agreement.

    -18- 

     

    

(b)              
 In the event the parties agree to resolve any dispute hereunder prior to an adjudication by a court of competent jurisdiction, each
party shall be responsible for its respective attorneys’ fees and expenses.

Article
VII

TAKING, casualty AND BROKERS

Section 7.1          
Taking or Casualty. In the event of a taking of a portion of the Land by the power of eminent domain or a fire or other casualty
causing damage or destruction to the Real Property, Seller shall promptly notify Purchaser and Purchaser shall be afforded the opportunity
to participate in any discussions or consultations with condemning authorities and Seller’s insurance companies in the adjustment
of any insurance claim. In the event of a taking of a portion of the Land by the power of eminent domain or a fire or other casualty
causing damage or destruction to the Real Property which is not “Major” (as defined in Section 7.3), this Agreement shall
remain in full force and effect, Purchaser shall pay Seller the Purchase Price in accordance with Sections 1.2 and 1.3, and Seller shall
pay over and assign to Purchaser in connection with the Closing all of Seller’s right, title and interest to any claims and proceeds
Seller may have with respect to any condemnation awards relating to the Real Property or insurance proceeds relating to the casualty;
however, Purchaser shall be entitled to a credit in the Purchase Price in the amount of any deductible under Seller’s insurance
policies or any self-insured retention.

Section 7.2          
Major Taking or Casualty. In the event of a “Major” taking of the Land by the power of eminent domain or a fire
or other casualty causing damage or destruction to the Real Property which is “Major”, Purchaser may terminate this Agreement
by written notice to Seller and Escrow Agent and receive the Deposit, in which event the parties hereto shall have no further rights
or obligations hereunder, other than those that by their terms survive the termination of this Agreement. If Purchaser does not elect
to terminate this Agreement within thirty (30) days after Seller sends Purchaser written notice of the occurrence of a Major taking or
casualty, then Purchaser shall be deemed to have elected to proceed with the consummation of the Closing, in which event Seller shall
pay over and assign to Purchaser in connection with the Closing all of Seller’s right, title and interest to any claims and proceeds
Seller may have with respect to any condemnation awards relating to the Real Property or insurance proceeds relating to the casualty
and Purchaser shall pay Seller the Purchase Price on the Closing Date without abatement or reduction; except that Purchaser shall be
entitled to a credit in the Purchase Price in the amount of any deductible under Seller’s insurance policies or any self-insured
retention.

Section 7.3          
Definition of “Major” Taking and Casualty. For purposes of Sections 7.1 and 7.2 hereinabove, “Major”
taking or casualty shall mean: (i) in the case of damage, damage to the Real Property such that the cost to repair or replace such damage
is likely to exceed seven percent (7%) of the Purchase Price or otherwise materially adversely impacts Purchaser’s intended use
of the Property, in Purchaser’s reasonable discretion, or, (ii) in the case of a condemnation or taking by a by the power of eminent
domain, a taking which negatively impacts the value of the Real Property by more than seven percent (7%) or which results in the Real
Property not having reasonable access to a publicly-dedicated street or otherwise materially adversely impacts Purchaser’s intended
use of the Property, in Purchaser’s reasonable discretion.

    -19- 

     

    

Section 7.4          
Brokerage Commissions. Seller and Purchaser each represent that they dealt with no brokers in connection with the transaction contemplated
by this Agreement. Each party agrees that should any claim be made for brokerage commissions or finder’s fees by any other broker
or other finder by, through or on account of any acts of said party or its representatives, said party will indemnify and hold the other
party free and harmless from and against any and all loss, liability, cost, damage and expense in connection therewith. Seller and Purchaser
agree that the provisions of this Section 7.4 shall survive the Closing.

Article
VIII

Miscellaneous

Section 8.1          
PURCHASER ACKNOWLEDGES AND AGREES THAT, EXCEPT AS EXPRESSLY SET FORTH IN THIS AGREEMENT OR IN THE DOCUMENTS TO BE DELIVERED IN CONNECTION
WITH THE CLOSING (THE “CLOSING DOCUMENTS”), NEITHER SELLER, NOR ANY AGENT OR REPRESENTATIVE OF SELLER HAS MADE, AND SELLER
IS NOT LIABLE OR RESPONSIBLE FOR OR BOUND IN ANY MANNER BY, ANY EXPRESS OR IMPLIED REPRESENTATIONS, WARRANTIES, COVENANTS, AGREEMENTS,
OBLIGATIONS, GUARANTEES, STATEMENTS, INFORMATION OR INDUCEMENTS PERTAINING TO THE PROPERTY OR ANY PART THEREOF, TITLE TO THE PROPERTY,
THE PHYSICAL CONDITION THEREOF, THE FITNESS AND QUALITY THEREOF, THE VALUE AND PROFITABILITY THEREOF, OR ANY OTHER MATTER OR THING WHATSOEVER
WITH RESPECT THERETO. WITHOUT LIMITING THE FOREGOING, PURCHASER ACKNOWLEDGES AND AGREES THAT, EXCEPT AS EXPRESSLY SET FORTH IN THIS AGREEMENT
OR IN THE CLOSING DOCUMENTS, NEITHER SELLER NOR ANY MEMBER, EMPLOYEE, AGENT OR REPRESENTATIVE OF SELLER IS LIABLE OR RESPONSIBLE FOR
OR BOUND IN ANY MANNER BY (AND PURCHASER HAS NOT RELIED UPON) ANY VERBAL OR WRITTEN OR IMPLIED REPRESENTATIONS, WARRANTIES, COVENANTS,
AGREEMENTS, OBLIGATIONS, GUARANTEES, STATEMENTS, INFORMATION OR INDUCEMENTS PERTAINING TO THE PROPERTY OR ANY PART THEREOF, AND ANY OTHER
INFORMATION RESPECTING SAME FURNISHED BY OR OBTAINED FROM SELLER OR ANY AGENT OR REPRESENTATIVE OF SELLER. PURCHASER ACKNOWLEDGES AND
AGREES THAT, EXCEPT AS OTHERWISE PROVIDED IN THIS AGREEMENT OR IN THE CLOSING DOCUMENTS, PURCHASER IS PURCHASING THE PROPERTY IN ITS
“AS IS” CONDITION and “WITH ALL FAULTS” AT THE DATE HEREOF, REASONABLE WEAR AND TEAR FROM THE DATE HEREOF UNTIL
THE CLOSING EXCEPTED.

Section 8.2          
Intentionally omitted.

Section 8.3          
Discharge of Obligations. The acceptance of the Deed for the Real Property by Purchaser shall be deemed to be a full performance
and discharge of every covenant made by Seller herein, except those which are herein specifically stated to survive the Closing. Likewise,
the acceptance of the Purchase Price by Seller shall be deemed to be a full performance and discharge of every covenant made by Purchaser
herein, except those which are herein specifically stated to survive the Closing.

    -20- 

     

    

Section 8.4          
Assignment. Purchaser shall have the right, without Seller’s consent but upon written notice to Seller (which notice shall
also include a copy of the relevant instrument of assignment and assumption agreement between Purchaser and its assignee), to assign
this Agreement to a wholly owned subsidiary of Purchaser or another entity which assumes all of Purchaser’s
obligations hereunder. Purchaser may similarly have the right to designate, upon written notice to Seller, any other entity to be the
grantee or transferee to take title to the Property at Closing. No assignment or designation by Purchaser shall relieve Purchaser from
any of its obligations hereunder.

Section 8.5          
Notices. Any notice pursuant to this Agreement shall be given in writing by (a) personal delivery, or (b) reputable overnight
delivery service with proof of delivery, or (c) e-mail transmission sent to the intended addressee at the e-mail address set forth below
(with prompt follow-up notice sent by one of the other means of delivery set forth in (a) or (b) above, within one (1) Business Day),
or to such other address or to the attention of such other person as the addressee shall have designated by written notice sent in accordance
herewith, and shall be deemed to have been given upon receipt or refusal to accept delivery by personal delivery, or, in the case of
reputable overnight delivery, on the next Business Day after deposit with the reputable overnight delivery service, or, in the case of
e-mail transmission, as of the date of the e-mail transmission if made before 5 pm, Eastern Time on a Business Day (or if not, on the
following Business Day). Unless changed in accordance with the preceding sentence, the addresses for notices given pursuant to this Agreement
shall be as follows:

 

If to Seller: 

SOUTHERN
RESEARCH INSTITUTE

2000 Ninth Avenue South

Birmingham, AL 35205

Attention: Joshua D.
Carpenter, Ph.D.

E-mail: jcarpenter@southernresearch.org

 

With a copy to:

Helena
F. Christine

UA System Office of Counsel

701 20th Street
South ( 1720 2nd Avenue South)

Suite AB 820

Birmingham, AL 35233
(35294-0108)

E-mail: hchristine@uasystem.edu

 

If to Purchaser:

TONIX
PHARMACEUTICALS HOLDING CORP.

26 Main Street

Chatham, NJ 07928

Attention: Seth Lederman,
M.D., Chief Executive Officer

E-mail: seth.lederman@tonixpharma.com

 

with a copy to:

Lowenstein
Sandler LLP

One Lowenstein Drive

Roseland, New Jersey 07068,

Attention: Michael Lerner, Esq.

E-mail: mlerner@lowenstein.com

 

    -21- 

     

    

 

If to Escrow Agent:

First
American Title Insurance Company

666 Third Avenue

New York, NY 10017

Attention: Larissa Kravanja

E-mail: lkravanja@firstam.com

 

Section 8.6          
Modifications. This Agreement cannot be changed orally, and no agreement shall be effective to waive, change, modify or discharge
it in whole or in part unless such agreement is in writing and is signed by the parties against whom enforcement of any waiver, change,
modification or discharge is sought.

Section 8.7          
Time of the Essence. Subject to the cure periods for default set forth in Sections 6.1 and 6.2, respectively, time is hereby
made strictly of the essence of this Agreement and the consummation of the transactions contemplated hereby. In every instance in this
Agreement where a time period is provided, such time period shall be strictly enforced.

Section 8.8          
Successors and Assigns. The terms and provisions of this Agreement are to apply to and bind the permitted successors and assigns
of the parties hereto.

Section 8.9          
Entire Agreement. This Agreement, including the exhibits and schedules hereto, contains the entire agreement between the parties
hereto pertaining to the subject matter hereof and fully supersedes all prior written or oral agreements and understandings between the
parties pertaining to such subject matter.

Section 8.10      
Further Assurances. Each party hereto agrees that it will execute and deliver such other documents and take such other action,
whether prior or subsequent to the Closing, as may be reasonably requested by the other party to consummate more effectively the purposes
or subject matter of this Agreement. The provisions of this Section 8.10 shall survive the Closing.

Section 8.11      
Counterparts and Electronic Signatures. This Agreement may be executed in counterparts, and may also be executed electronically
by email, facsimile, DocuSign or other .pdf signatures, and all such executed counterparts shall constitute the same agreement. It shall
be necessary to account for only one such counterpart in proving this Agreement.

Section 8.12      
Severability. If any provision of this Agreement is determined by a court of competent jurisdiction to be invalid or unenforceable,
the remainder of this Agreement shall nonetheless remain in full force and effect.

Section 8.13      
Applicable Law. This Agreement shall be governed by, and construed in accordance with the laws of the State of Maryland. Seller
and Purchaser hereby irrevocably submit to the jurisdiction of the courts of the State of Maryland and/or federal courts sitting in the
State of Maryland in any action or proceeding arising out of or relating to this Agreement and hereby irrevocably agree that all claims
in respect of such action or proceeding shall be heard and determined by such courts. Purchaser and Seller agree that the provisions
of this Section 8.13 shall survive the Closing.

    -22- 

     

    

Section 8.14      
No Third-Party Beneficiary. The provisions of this Agreement and of the documents to be executed and delivered in connection with
the consummation of the Closing are and will be for the benefit of Seller and Purchaser and Escrow Agent only and are not for the benefit
of any third party, and accordingly, no third party shall have the right to enforce the provisions of this Agreement or of the documents
to be executed and delivered in connection with the consummation of the Closing.

Section 8.15      
Exhibits and Schedules. The schedules and/or exhibits attached hereto shall each be deemed to be an integral part of this
Agreement.

Section 8.16      
Captions. The section headings appearing in this Agreement are for convenience of reference only and are not intended, to
any extent and for any purpose, to limit or define the text of any section or any subsection hereof.

Section 8.17      
Construction. The parties acknowledge that the parties and their counsel have reviewed and revised this Agreement and that
the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed
in the interpretation of this Agreement or any exhibits or amendments hereto.

Section 8.18      
Termination of Agreement. It is understood and agreed that if either Purchaser or Seller terminates this Agreement pursuant
to a right of termination granted hereunder, such termination shall operate to relieve Seller and Purchaser from all obligations under
this Agreement, except for such obligations as are specifically stated herein to survive the termination of this Agreement.

Section 8.19      
Recordation. Neither this Agreement nor any notice thereof may be recorded by any party hereto without the prior written consent
of the other party hereto. The provisions of this Section 8.19 shall survive the Closing.

Section 8.20      
1031 Exchange. The parties hereto acknowledges that either party may desire to effect a tax-deferred like-kind exchange with
respect to its purchase of the Real Property pursuant to Section 1031 of the Internal Revenue Code and any similar provisions of State
or local law (an “Exchange”). Subject to the terms and provisions of this Section, the parties shall reasonably cooperate
with each other in effecting any Exchange; provided, however, in no event shall either party be required to incur any liability,
any delays, any costs or expenses or risk of ownership, title or conveyance in connection with such cooperation with the party not entering
into an Exchange (the “Non-Exercising Party”). Any Exchange will be structured by the party exercising its right to
enter into an Exchange (the “1031 Party”) at its sole cost and expense such that the Non-Exercising Party will have
no obligation to acquire or enter into the chain of title to any property other than the Land. The Non-Exercising Party shall not be
responsible for compliance with or be deemed to have warranted to the 1031 Party that any Exchange in fact complies with Section 1031
of the Internal Revenue Code. The Non-Exercising Party shall have the right to review and approve any documents to be executed by the
1031 Party in connection with any Exchange; provided, however, such approval shall not be unreasonably withheld, conditioned
or delayed as long as the Non-Exercising Party will not incur any liability or any cost or expense as a result thereof and the 1031 Party
shall not be released from any of its obligations under this Agreement. The Non-Exercising Party shall have no obligation to execute
any

    -23- 

     

    

documents or to undertake any action by which
the Non-Exercising Party would or might incur any liability or obligation not otherwise provided for in the other provisions of this
Agreement. Neither the conveyance of title to the Land to the 1031 Party’s designated intermediary, or qualified exchange accommodation
title holder (if applicable), nor the Exchange shall modify the representations, warranties and covenants of either party under this
Agreement or the survival thereof pursuant to this Agreement in any respect, nor shall any such conveyance or Exchange result in a release
of the 1031 Party with respect to such representations, warranties and/or covenants. At the 1031 Party’s request, the Deed and
the other documents that shall be executed and delivered to consummate the Closing shall be executed by and run in favor of the 1031
Party’s designated intermediary or qualified exchange accommodation title holder; provided, however, the 1031 Party
shall remain obligated to the Non-Exercising Party for any obligation under any and all such closing documents. The Closing Date shall
not be extended or adjourned as a result of any Exchange. The 1031 Party hereby agrees to indemnify and hold the Non-Exercising Party
harmless from and against any and all costs and liabilities arising from any Exchange (other than what would have been applicable under
this Agreement without such Exchange), which indemnification obligation shall expressly survive the Closing and not be merged therein.
The 1031 Party further acknowledges that any Exchange is at the request and initiation of the 1031 Party and that the 1031 Party is relying
solely upon the advice and counsel of professionals of its choice in structuring, executing and consummating any Exchange.

Section 8.21      
Exclusivity. Seller agrees that while this Agreement remains in full force and effect, Seller shall not negotiate for the
sale of the Property, make or accept any offers to sell the Property, nor market the Property in any way, to any other person or entity
other than Purchaser and its permitted assignees.

 

[Remainder of page intentionally left
blank; signatures to follow]

 

    -24- 

     

    

IN WITNESS WHEREOF, the
parties hereto have duly executed this Agreement as of the Effective Date.

 

 

SELLER:

 

SOUTHERN RESEARCH INSTITUTE,

An Alabama non-profit corporation

 

 

By:                                                                

Name: Joshua D. Carpenter, Ph.D.

Title: President and Chief Executive Officer

 

 

 

PURCHASER:

 

TONIX PHARMACEUTICALS HOLDING CORP.,
a Nevada corporation,

 

By:                                                                

Name:

Title:

 

 

Signature Page – Agreement of Purchase and Sale

     

     

    

Escrow Agent agrees to act
as escrow agent hereunder and to hold and disburse the Deposit in the manner provided herein.

 

ESCROW AGENT:

 

FIRST AMERICAN TITLE INSURANCE COMPANY

 

 

 

By:_______________________________

Name:

Title:

 

 

 

-26-

     

     

    

EXHIBIT A

DESCRIPTION OF LAND

 

 

 

Parcel ID: 02218542

 

 

Address: 431 Aviation Way, Frederick , MD 21701

 

 

 

BEING all of the real estate
described and conveyed to Southern Research Institute by deed dated January 30, 1990, from Frederick Business Properties Company, and
recorded in the Land Records of Frederick County, Maryland at Book 1620, Page 1023.

 

AND BEING all of the real estate
described and conveyed to Frederick Business Properties Company from Aircraft Owners and Pilots Association, and recorded in the Land
Records of Frederick County, Maryland at Book 1386, Page 942.

 

 

     

     

    

EXHIBIT B

 

EQUIPMENT

 

 

 

 

 

 

     

     

    

EXHIBIT C

INSPECTION DOCUMENTS

 

	 	Description
    of Requested Item(s), to be provided by Seller to the extent in Seller’s possession.
	1	Existing Owner’s
    Title Policy, including all Schedules.
	2	Deeds, titles, licenses,
    charges, liens, options, agreements or any other Real Property instruments which relate to the business being conducted at the Premises.
	3	Most recent appraisal.
	4	Most recent property
    and zoning report.
	5	Site plan and surveys.
	6	If the Land is located
    in a flood zone, flood insurance certificates.
	7	If issued by the
    applicable governmental authority, copies of all certificates of compliance (i.e. certificates of occupancy, zoning verification,
    etc.).
	8	Plans and specifications
    for any improvements.
	9	Current operating
    licenses or permits for Property.  
	10	Existing physical
    condition assessments/report.
	11	Health, fire and
    building inspections from governmental agencies during past twelve (12) months.   
	12	Written notices
    from governmental authorities and insurance carriers received within the past twelve (12) months.
	13	Insurance certificates.
	14	Current loss history
    for property and liability claims at the Property, for the preceding three year period.
	15	Inventory of capital
    improvements made (by year for 2021 YTD, 2020, 2019 and 2018).
	16	Deferred maintenance
    schedule.
	17	Tax bills for the
    two (2) years immediately preceding the month in which the Effective Date occurs and current year and notices of assessment.

     

     

    

 

	18	Copies
    of the 5 HJF research contracts and the 1 NIAID research contract, as well as copies of all other vendor/service/operational contracts
    and leases, including utility contracts.
	19	If any space is
    leased to a tenant, copies of all leases
	20	Documents evidencing
    and/or securing any mortgage loan (as applicable).
	21	Copies of all reports,
    notices or correspondence concerning any violation or infringement of a government regulation by any part of Business, including
    the areas of: permits, licenses and approvals; occupational safety and health; and environmental protection.
	23	Description of all
    equipment, assets and inventory located at the Property, including depreciation and amortization records.
	24	All engineering, financial, and architectural information
    related to the reconstruction of a substantial portion of the building after the 2015 flood.

     

 

     

     

    

EXHIBIT D

GENERAL WARRANTY DEED

 

THIS GENERAL WARRANTY DEED is
made this ______ day of ______________, 2021, by and between SOUTHERN RESEARCH INSTITUTE, an Alabama non-profit organization,
with an address at 2000 Ninth Avenue South, Birmingham, Alabama 35205, as grantor (“the “Grantor) to and in favor
of TONIX PHARMACEUTICALS HOLDING CORP., a Nevada corporation, with an address at 26 Main Street, Chatham, New Jersey 07928, as
grantee (“the Grantee”).

 

WITNESSETH: For and in consideration
of the sum of SEVENTEEN MILLION FIVE HUNDRED THOUSAND AND 00/100 DOLLARS ($17,500,000.00) , and other good and valuable consideration
paid in hand to Grantor by Grantee, the receipt and sufficiency of which are hereby acknowledged, Grantor has GRANTED, BARGAINED, SOLD
and CONVEYED, and by these presents does grant bargain, sell and convey unto Grantee, its successors and assigns, in fee simple, the
real property, as the same is legally and particularly described on Exhibit A attached hereto, and incorporated herein by reference
(“the Real Property”), together with all and singular rights, benefits, privileges, easements, rights of way, tenements,
hereditaments, appurtenances, and other interests, in anyway appertaining or belonging to the Real Property, including any such interests
on, in, or under, any land, highway, alley, street or right of way abutting or adjoining the Real Property, subject to any mineral rights
not owned by the Grantor, and all buildings, structures, fixtures, facilities, and other improvement located on, under or above the Real
Property, subject to those Covenants, Conditions, Restrictions and Reservations recorded in Liber 1155, Folio 352 and Liber 1386, Folio
942 of the Land Records of Frederick County, Maryland (to the extent such matters apply to the Real Property) and subject to the Permitted
Exceptions set forth in Exhibit B attached hereto and made a part hereof (the “Permitted Exceptions”). To have and to hold
the Real Property hereby conveyed to the Grantee, its successors and assigns, in fee simple forever.

 

AND GRANTOR covenants that it
will warrant generally the described real property hereby granted and conveyed, and that it will execute such further assurances of the
described real property as may be requisite.

 

IN WITNESS WHEREOF, Grantor,
on the day and year first hereinabove written, has caused these presents to be executed, under seal, by its President and Chief Executive
Officer.

 

WITNESS:

GRANTOR:

 

SOUTHERN RESEARCH INSTITUTE

an Alabama non-profit organization

 

 

By: _____________________________(SEAL)

       Name: Joshua D. Carpenter, Ph.D.

       Title: President and Chief Executive Officer

 

 

     

     

    

 

 

STATE OF ALABAMA

COUNTY OF JEFFERSON

 

I, the undersigned, a Notary Public in and for the
said County in said State, hereby certify that Joshua D. Carpenter, whose name as the President and Chief Executive Officer of Southern
Research Institute is signed to the foregoing conveyance, and who is known to me, acknowledged before me on this day that, being informed
of the contents of the conveyance, he, as such officer and with full authority, executed the same voluntarily for and as the act of said
organization.

 

Given under my hand this _____ day of ___________________, 2021.

 

 

_______________________________

Notary Public

 

My commission expires: ___________________

 

 

I HEREBY CERTIFY, that the forgoing
General Warranty Deed was prepared by or under the supervision of the undersigned, an attorney licensed to practice law by the Court
of Appeals of Maryland.

 

 

______________________________

Raymond Daniel Burke

Baker, Donelson, Bearman

     Caldwell & Berkowitz

100 Light Street, 19th Floor

Baltimore, Maryland 21202

410-862-1192

rburke@bakerdonelson.com       

 

     

     

    

Exhibit A

 

LEGAL DESCRIPTION

 

Parcel ID: 02218542

 

 

Address: 431 Aviation Way, Frederick , MD 21701

 

 

 

BEING all of the real estate
described and conveyed to Southern Research Institute by deed dated January 30, 1990, from Frederick Business Properties Company, and
recorded in the Land Records of Frederick County, Maryland at Book 1620, Page 1023.

 

AND BEING all of the real estate
described and conveyed to Frederick Business Properties Company from Aircraft Owners and Pilots Association, and recorded in the Land
Records of Frederick County, Maryland at Book 1386, Page 942.

 

     

     

    

 

 

Exhibit B

 

PERMITTED EXCEPTIONS

 

 

 

     

     

    

EXHIBIT E

 

OMNIBUS BILL OF SALE, ASSIGNMENT AND
ASSUMPTION

 

THIS OMNIBUS BILL OF SALE, ASSIGNMENT AND ASSUMPTION
(this “Assignment”) is made as of ________, 2021 by and between SOUTHERN RESEARCH INSTITUTE, an Alabama non-profit
corporation, having an address at 2000 Ninth Avenue South, Birmingham, AL 35205(“Assignor”) and TONIX PHARMACEUTICALS
HOLDING CORP, a Nevada corporation, having an address at 509 Madison Avenue, Suite 306, New York, NY 10022 (“Assignee”).

 

R E C I T A L S:

A.       Effective
contemporaneously herewith, Assignor has conveyed to Assignee certain real property described on Exhibit “A” (the “Real
Property”) located in Frederick, Maryland pursuant to the terms of that certain Agreement of Purchase and Sale, dated as of July
26, 2021, by and between Assignor and Assignee (as the same may have been amended, modified or assigned, the “Sale Agreement”).

B.       In
connection with the conveyance of the Real Property, Assignor has agreed to transfer, convey and assign to Assignee all of Assignor’s
right, title and interest in and to (a) all open or proposed highways, streets, roads, avenues, alleys, easements, strips, gores and
rights of way in, on, across, in front of, contiguous to, abutting or adjoining the Real Property; (b) any and all buildings, structures,
fixtures and other improvements now or hereafter erected on the Real Property (“Improvements”); (c) any and all personal
property used in the operation, maintenance or ownership of the Real Property including without limitation the Equipment (as defined
in the Sale Agreement); (d) all water (including riparian, drilling and pumping), sewer, development, and other rights or any nature
appurtenant to the Real Property or the Improvements; (e) all permits, licenses, approvals, authorizations issued by any governmental
authority in connection with the Property or the Improvements (as opposed to the Equipment), (f) the Permits (as defined in the Sale
Agreement) listed on Schedule A attached hereto (collectively, the “Other Property”).

NOW, THEREFORE, in consideration
of the purchase of the Property and of the mutual covenants herein set forth and for Ten Dollars ($10.00) and other good and valuable
consideration, the parties hereto agree as follows:

1.                 
Assignment. Assignor hereby sells, assigns, and transfers to Assignee all of Assignor’s right, title and interest in and
to the Other Property.

2.                 
Assumption. Assignee hereby assumes all of Assignor’s rights and obligations in respect of the Other Property from and after
the date hereof.

 

3.                 
Permits. [OPEN]1

1
Note: Any permit specific considerations can be built-in here at closing.

     

     

    

 

4.                 
Successors and Assigns. This Assignment shall be binding on the successors and assigns of Assignor. Assignor shall execute such
further and additional documents as may be necessary to evidence or carry out the provisions of this Assignment.

 

5.              
Representation or Warranty. This Assignment is made without representation or warranty by Assignor, except as set forth in the
Sale Agreement.

 

[Remainder of page intentionally left
blank; signatures to follow]

 

 

     

     

    

IN WITNESS WHEREOF, Assignor has executed
or have caused this Assignment to be properly executed on the day and year set forth above.

 

 

ASSIGNOR:

 

SOUTHERN RESEARCH INSTITUTE,

An Alabama non-profit corporation

 

By:                                            

Name:

Title:

 

 

 

ASSIGNEE:

 

TONIX PHARMACEUTICALS HOLDING CORP.,
a Nevada corporation,

 

By:                                            

Name:

Title:

 

 

     

     

    

Schedule A

 

Permits

 

 

 

 

     

     

    

EXHIBIT F

FIRPTA AFFIDAVIT

 

Section 1445 of the Internal
Revenue Code provides that a transferee of a United States real property interest must withhold tax if the transferor is a foreign person.
For U.S. tax purposes (including Section 1445), the owner of a disregarded entity (which has legal title to a U.S. real property interest
under local law) will be the transferor of the property and not the disregarded entity. To inform the transferee that withholding of
tax is not required upon the disposition of a United States real property interest by SOUTHERN RESEARCH INSTITUTE, an Alabama
non-profit corporation (“Seller”), under penalties of perjury, the undersigned hereby certifies the following on behalf of
Seller:

1.       Seller
is not a foreign corporation, foreign partnership, foreign trust, foreign estate or non-resident alien (as those terms are defined in
the Internal Revenue Code and Income Tax Regulations); and

2.       Seller
is not a disregarded entity as defined in §1.1445-2(b)(2)(iii) of the Income Tax Regulations; and

3.       Seller’s
U.S. employer taxpayer identification number is 63-0288868; and

4.       Seller’s
office address is 2000 Ninth Avenue South, Birmingham, AL 35205.

Seller understands that
this certification may be disclosed to the Internal Revenue Service by transferee and that any false statement contained herein could
be punished by fine, imprisonment, or both.

Under penalties of perjury,
Seller declares that it has examined this certification and to the best of Seller’s knowledge and belief it is true, correct and
complete, and that the individual executing this certification has authority to sign this document on behalf of Seller.

Dated:                          ,
2021.

SOUTHERN RESEARCH INSTITUTE,

An Alabama non-profit corporation

 

 

By:                                             

Name: Joshua D. Carpenter, Ph.D.

Title: President and Chief Executive Officer

     

     

    

	STATE OF ALABAMA	§
	 	§
	COUNTY OF JEFFERSON	§

 

On                         ,
2021, before me, the undersigned, a notary public in and for said State, personally appeared Joshua D. Carpenter, personally known to
me (or proved to me on the basis of satisfactory evidence) to be the person(s) whose name(s) is/are subscribed to the within instrument
and acknowledged to me that he/she/they executed the same in his/her/their authorized capacity(ies) and that, by his/her/their signature(s)
on the instrument, the person(s), or the entity upon behalf of which the person(s) acted, executed the instrument.

____________________________, Notary Public

My Commission Expires:

 

_____________________

 

 

 

 

     

     

    

EXHIBIT G

PERMITSEX-10.14

   

  Exhibit 10.14

   

  

  July 2, 2021

  Dear Jennifer Fulk, 

   

  Talkspace, Inc.  (the "Company") is very pleased to offer you the position of Chief Financial Officer reporting directly to the Company's CEO with an anticipated start date of July 26 2021.  You shall devote your full working time, attention and best efforts to fulfill your duties and to further the business and interests of the Company.

   

  1.Annual Base Salary.  You will receive an annual salary of $400,0000 subject to tax and other withholdings as required by law, which will be paid semi-monthly in accordance with the Company's normal payroll procedures (your “Base Salary”).  Your Base Salary may be adjusted from time to time in accordance with normal business practice and at the sole discretion of the Company.  You shall be an “exempt” employee not working hourly or eligible for overtime.

  Bonus.  You will be eligible for an annual bonus under the Company’s annual incentive program (your “Annual Bonus”).  Your target Annual Bonus will be equal to 100% of your Base Salary, evenly divided between Individual and Company goals.  You have the potential to achieve up to an additional one hundred percent (100%) of your Base Salary based on achieving max goals as defined by the Talkspace Strategic Scorecard. Total annual bonus compensation eligibility is therefore 200% of your base salary. Your Annual Bonus will be awarded based on the achievement of both individual and Company goals as communicated to you by the Company on an annual basis, and subject to the terms and conditions of the applicable program.   For the year ending 2021, the Company will guarantee the minimum bonus earned will equal no less than fifty percent (50%) of the base salary.

   

  Signing Bonus. At the completion of your first thirty days of employment with the Company, you will receive a signing bonus of two hundred thousand dollars ($200,000) payable through the Company payroll system.

   

  2.Equity Award.  

  a.Subject to approval of the Board of Directors of the Company (or a subcommittee thereof) (the “Board”), the Company shall grant to you equity-based compensation awards under the Talkspace, Inc. 2021 Incentive Award Plan (the “Plan”) The Plan is ongoing, but the initial shares described herein reflect the staking grant tied to Talkspace Inc.’s public company filing in June 2021.  Under this staking grant you will be entitled to vest in an aggregate share number equal to 615,750 shares.  Of that amount, 20% or 123,150 units will be granted in the form of a restricted stock unit award (the “RSU Award”) and the remaining 80% (492,600) shall be granted in the form of an option to purchase Company common stock (the “Stock Option” and, together with the RSU Award, the “Award”), in each case, subject to your continued employment through the applicable vesting date.

  1

   

  

   

  b.Beginning in the calendar year 2022, you will be eligible to receive an annual equity-based award as determined by the Board from time to time. This annual grant is not connected to the staking grant and will reflect industry standards for annual equity awards for your position. 

  c.For your annual grants, the number of shares of Company common stock subject to any RSU Award will be determined by dividing the applicable RSU Award grant value by the Fair Market Value (as defined in the Plan) of the Company’s common stock on the applicable grant date.  

  d.For your annual grants, the Stock Option shall be a non-qualified stock option, shall have an exercise price per share equal to the Fair Market Value of the Company’s common stock on the applicable grant date, and shall have a maximum term of ten years from the applicable grant date.  The number of shares of Company common stock subject to the Stock Option will be determined by dividing the applicable Stock Option grant value by the per share Black-Scholes valuation as of the applicable grant date, utilizing the same assumptions that the Company uses in the preparation of its financial statements. 

  e.Subject to your continued service with the Company through the applicable vesting date, both the staking grant and the annual grant shall vest (and become exercisable, as applicable) (x) with respect to 25% of the shares underlying such Award, on the first anniversary of the grant date, and (y) as to the remaining 75% of the shares underlying such Award, in substantially equal installments on each of the 12 quarterly anniversaries thereafter. The terms and conditions of each Award shall be set forth in one or more separate award agreement(s) in a form(s) prescribed by the Company, to be entered into by the Company and you (the “Award Agreements”).  Except as otherwise specifically provided in this Agreement, each Award shall be governed in all respects by the terms of and conditions of the Plan and the applicable Award Agreement.

  3.Benefits.  During your employment, you will be entitled to the benefits generally made available to regular, full-time salaried employees of the Company as summarized in the attached Benefits Overview.  The Company reserves the right to adjust its benefits program from time to time as the Company sees fit.

  4.Conditions to Employment.  As a condition of your employment, you are required to review and sign the Invention, Non-Disclosure, Non-Competition and Non-Solicitation Agreement attached hereto as Exhibit A (the “Restrictive Covenant Agreement”) and the Company’s Employee Handbook.  You will also be required to complete applicable immigration, payroll and tax forms, and to provide documentation of your eligibility to work in the United States, as required by the Immigration Reform and Control Act of 1986.

   

  5.“At-Will” Employment.  Your employment with the Company is for no specified period and constitutes "at-will" employment in that it can be terminated with or without cause, and with or without notice, at any time, at the option of either the Company or yourself, except as otherwise provided by law. All issues related to separation and severance are covered separately in the Talkspace Executive Severance Plan. Similarly, nothing in this letter shall be construed as an agreement, either express or implied, to pay you any compensation or grant you any benefit beyond the end of your employment with the Company. 

  2

   

  

   

  6.Entire Agreement.  This letter, along with the Restrictive Covenant Agreement, sets forth the terms of your employment with the Company and supersedes any prior representations or agreements whether written or oral. 

  7.Miscellaneous.  

  a.The validity, interpretation, enforceability, and performance of this letter shall be governed by and construed in accordance with the laws of the State of New York, without giving effect to conflict of laws provisions thereof. Each party hereto hereby consents to the personal and exclusive jurisdiction and venue of the courts of the State of New York and expressly waives any claim of improper venue and any claim that such courts are an inconvenient forum. By your acceptance of this offer letter, you agree to submit to the jurisdiction of such courts.

  b.You represent that you are not bound by any employment contract, restrictive covenant or other restriction preventing you from entering into employment with or carrying out your responsibilities for the Company, or which is in any way inconsistent with the terms of this letter.

  	If you agree with and accept the terms of this offer of employment, please sign below and return this letter to me.  This offer shall expire in three business days; however, if you need additional time to consider, please contact us at peopleops@talkspace.com.  We look forward to having you join Talkspace.

  					

   

   

  Very truly yours,

   

  /s/ Oren Frank												

  Oren Frank

  CEO

  Talkspace, Inc.

   

  						

  			

  AGREED AND ACCEPTED BY:

   

  /s/ Jennifer Fulk						

  Jennifer Fulk

   

  Date: 	6/28/2021				

   

   

  3

   

  

   

  EXHIBIT A

   

  Invention, Non-Disclosure, Non-Competition and Non-Solicitation Agreement

   

  This Invention, Non-Disclosure, Non-Competition and Non-Solicitation Agreement (hereinafter referred to as the “Agreement”) is dated as of June 25, 2021 (hereinafter referred to as the “Effective Date”) and is between: Talkspace, Inc. (d.b.a. Talkspace) (hereinafter the “Company”), having a place of business at 2578 Broadway #607, New York, NY 10025, and Jennifer Fulk (hereinafter referred to in the first person as "I," "me" or "my").

  										

  In consideration for my engagement by the Company, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, I hereby agree as follows:

   

  1.Inventions and Patents.

  1.1	I will promptly and fully disclose to the Company any and all inventions, discoveries, trade secrets and improvements, whether or not patentable and whether or not they are made, conceived or reduced to practice during working hours or using the Company's data or facilities, which I develop, make, conceive or reduce to practice during my engagement with the Company, either solely or jointly with others (collectively, the "Developments").  All Developments shall be the sole property of the Company, and I hereby assign to the Company, without further compensation, all my right, title and interest in and to the Developments and any and all related patents, patent applications, copyrights, copyright applications, trademarks, trademark applications and trade names in the United States and elsewhere.  Notwithstanding the foregoing, Developments shall not include any inventions, discoveries, trade secrets or improvements that: (i) are not made, conceived or reduced to practice during working hours; (ii) are not made, conceived or reduced to practice using the Company’s information, data or facilities; and (iii) do not relate to the present business of the Company, any business that is competitive therewith, or any future business in which the Company engages.

  1.2	I will keep and maintain adequate and current written records of all Developments (in the form of notes, sketches, drawings and as may be specified by the Company), which records shall be available to and remain the sole property of the Company at all times.

  1.3	I will assist the Company in obtaining and enforcing patent, copyright and other forms of legal protection for the Developments in any country.  Upon request, I will sign all applications, assignments, instruments and papers and perform all acts necessary or desired by the Company to assign all such Developments fully and completely to the Company and to enable the Company, its successors, assigns and nominees, to secure and enjoy the full and exclusive benefits and advantages thereof.  I understand that my obligations under this Paragraph 1 will continue after the termination of my engagement with the Company and that during my engagement I will perform such obligations without further compensation, except for reimbursement of expenses incurred at the request of the Company.  I further understand that if I am requested to perform any obligations under this Paragraph 1 after my engagement with the Company terminates, I shall receive for such performance a reasonable per diem fee, as well as reimbursement of any expenses incurred at the request of the Company.

  1.4	In addition to my agreements set forth in subparagraph 1.3, I hereby constitute and appoint the Company, its successors and assigns, my true and lawful attorney, with full power of substitution for me, and in my name, place and stead or otherwise, but on behalf of and for the benefit of the Company, its successors and assigns, to take all actions and execute all documents on behalf of me necessary to effect the assignment set forth in subparagraph 1.1, and from time to time to institute and prosecute in my name or otherwise, but at the direction and expense and for the benefit of the Company and its successors and 

  4

   

  

   

  assigns, any and all proceedings at law, in equity or otherwise, which the Company, its successors or assigns may deem proper in order to collect, assert or enforce any claim, right or title of any kind in and to the Developments and to defend and compromise any and all actions, suits and proceedings in respect of any of the Developments and to do any and all such acts and things in relation thereto as the Company, its successors or assigns shall deem advisable, and I hereby declare that the appointment hereby made and the powers hereby granted are coupled with an interest and are and shall be irrevocable by me in any manner or for any reason.

   

  1.5	In order to avoid disputes over the application of this assignment to prior inventions or copyrightable materials, I have listed on Schedule A to this Agreement descriptions of patentable inventions and copyrightable materials that I have developed and/or reduced to practice prior to my engagement with the Company and that I believe are, accordingly, excepted from the provisions of this Paragraph 1.

  2.Proprietary Information.

  2.1	I recognize that my relationship with the Company is one of high trust and confidence by reason of my access to and contact with the trade secrets and confidential and proprietary information of the Company and of others through the Company.  I will not at any time, either during my engagement with the Company or thereafter, disclose to others, or use for my own benefit or the benefit of others, any of the Developments or any confidential, proprietary or secret information owned, possessed or used by the Company (collectively, "Proprietary Information"). Such property shall not be erased, discarded or destroyed without specific instructions from the Company to do so.  By way of illustration, but not limitation, Proprietary Information includes trade secrets, processes, data, knowhow, marketing plans, forecasts, financial statements, budgets, licenses, prices, costs and employee, customer and supplier lists.  I understand that the Company from time to time has in its possession information which is claimed by others to be proprietary and which the Company has agreed to keep confidential.  I agree that all such information shall be Proprietary Information for purposes of this Agreement.

  2.2	My undertaking and obligations under this Paragraph 2 will not apply, however, to any Proprietary Information which:  (i) is or becomes generally known to the public through no action on my part; (ii) is generally disclosed to third parties by the Company without restriction on such third parties; (iii) is approved for release by written authorization of the Board of Directors of the Company; or (iv) is required to be disclosed pursuant to subpoena, order of judicial or administrative authority, or in connection with judicial proceedings to which the Company or I am a party, provided that I shall have given the Company written notice of such disclosure at least 14 days prior to such disclosure in order to provide the Company with an opportunity to oppose and/or object to such disclosure and any such disclosure is subject to all applicable governmental and judicial protection available for like material.

  2.3	Upon termination of my engagement with the Company or at any other time upon request, I will promptly deliver to the Company all copies of computer programs, specifications, drawings, blueprints, data storage devices, notes, memoranda, notebooks, drawings, records, reports, files and other documents (and all copies or reproductions of such materials) in my possession or under my control, whether prepared by me or others, in whatever form on whatever medium, which contain Proprietary Information. I acknowledge that this material is the sole property of the Company.

  2.4	If requested to do so by the Company, I agree to sign a Termination Certificate in which I confirm that I have complied with the requirements of the preceding paragraph and that I am aware that certain restrictions imposed upon me by this Agreement continue after termination of my engagement.  I understand, however, that my rights and obligations under this Agreement will continue even if I do not sign a Termination Certificate.

  5

   

  

   

  3.Absence of Restrictions Upon Disclosure and Competition.

  3.1	I hereby represent that, except as I have disclosed in writing to the Company, and included in Schedule A to this Agreement, I am not bound by the terms of any agreement with any previous employer or other party to refrain from using or disclosing any trade secret or confidential or proprietary information in the course of my engagement with the Company or to refrain from competing, directly or indirectly, with the business of such previous employer or any other party.

  3.2	I further represent that my performance of all the terms of this Agreement and my engagement with of the Company does not and will not breach any agreement to keep in confidence proprietary information, knowledge or data acquired by me in confidence or in trust prior to my engagement with the Company, and I will not disclose to the Company or induce the Company to use any confidential information or material belonging to any previous employer or others.

  4.Non-Compete/Non-Solicitation.

  4.1	For so long as I am engaged with the Company and for a period of 12 full months thereafter, I will not, without the express written consent of the Company, directly or indirectly, engage in, participate in, or assist, as owner, part-owner, partner, director, officer, trustee, employee, agent or consultant, or in any other capacity, any business organization or person, do business that is related to internet based behavioral health platforms. 

  4.2	I recognize that these restrictions on competition are reasonable because of the Company’s investment in good will and in its customer lists and other proprietary information and my knowledge of the Company’s business and business plans.  However if any period of time or geographical area should be judged unreasonable in any judicial proceeding, then the period of time or geographical area shall be reduced to such extent as may be deemed required so as to be reasonable and enforceable.

  4.3	During my engagement with the Company and for 12 full months thereafter, I will notify the Company in the event I take up a position of any sort with any company or person whose activities or products are directly or indirectly competitive with activities or products of the Company.

  4.4	I shall not recruit or otherwise solicit or induce any employees of the Company, to terminate their engagement with, or otherwise cease their relationships with, the Company or any of its subsidiaries during my engagement with the Company and for a period of 12 full months thereafter.  In addition, I shall not recruit or otherwise solicit any person who was an employee of the Company during any time within six (6) months prior to the end of my engagement with the Company.

  5.Other Obligations.

  5.1	I acknowledge that the Company from time to time may have agreements with others which impose obligations or restrictions on the Company regarding inventions made during the course of work under such agreements or regarding the confidential nature of such work.  I agree to be bound by all such obligations and restrictions which are made known to me and to take all action necessary to discharge the obligations of the Company under such agreements.

  5.2	Talkspace contracts with Therapist Consultants to provide certain services and acts, in this respect,  as a “Business Associate/ Covered Entity.”  As an Employee, you may incidentally or inadvertently encounter, view or access certain Confidential Information maintained by Talkspace which may qualify as Protected Health Information (“PHI”) or electronic PHI within the meaning of the Health Insurance Portability and Accountability Act of 1996, as amended, and the privacy and security standards promulgated pursuant thereto (“HIPAA”).  In this case, the definition of “Confidential Information” means 

  6

   

  

   

  any and all non-public, medical, financial and personal information in whatever form (written, oral, visual or electronic) possessed or obtained by either party. Confidential Information shall include all information which (i) either party has labeled in writing as confidential, (ii) is identified at the time of disclosure as confidential, (iii) is commonly regarded as confidential in the health care industry, or (iv) is PHI as defined by HIPAA.  You  agree that while  working with Talkspace to maintain the confidentiality of any PHI that you may incidentally or inadvertent encounter, view or have access as part of your employment. You also agree not to further use or disclose any PHI that you incidentally or inadvertently view or obtains access to and further agree to implement appropriate safeguards to prevent any further use or disclosure of any PHI that you incidentally or inadvertently access.  You agree to comply with all applicable laws and regulations, including HIPAA and the HITECH Act, to the extent applicable in your employment, to fulfill your obligations under this Agreement.  

   

  6.Miscellaneous.

  6.1	The partial or complete invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement.

  6.2	This Agreement supersedes all prior agreements, written or oral, between me and the Company relating to the subject matter of this Agreement.  This Agreement may not be modified, changed or discharged in whole or in part, except by an agreement in writing signed by me and the Company.  This Agreement does not constitute an engagement agreement, and no changes in my compensation, title or duties or any other terms or conditions of my engagement, including, without limitation, the termination of my engagement, shall affect the provisions of this Agreement except as stated herein.

  6.3	As used herein, the term “Company” shall include Talkspace Inc., Talkspace, Talkspace Network LLC, and any of its predecessors, subsidiaries, subdivisions or affiliates.  The Company shall have the right to assign this Agreement to its successors and assigns and all covenants and agreements hereunder shall inure to the benefit of and be enforceable by said successors or assigns. I agree not to assign any of my obligations under this Agreement.  This Agreement will be binding upon my heirs, executors and administrators. 

   

  6.4	No delay or omission by the Company in exercising any right under this Agreement will operate as a waiver of that or any other right.  A waiver or consent given by the Company on any one occasion is effective only in that instance and will not be construed as a bar to or waiver of any right on any other occasion.

   

  6.5	I expressly consent to be bound by the provisions of this Agreement for the benefit of the Company or any subsidiary or affiliate thereof to whom my engagement may be transferred without the necessity that this Agreement be re-signed at the time of such transfer.

  6.6	This Agreement shall be deemed to be a sealed instrument and shall be governed by and construed in accordance with the laws of the State of Delaware.  I hereby expressly consent to the jurisdiction of the courts of the state where the Company has its principal place of business in the United States (currently New York) to adjudicate any dispute arising under this Agreement.

  6.7	I recognize that irreparable damages would be caused to the Company, and that monetary damages would not compensate the Company for its loss, should I breach the terms of this Agreement.  Accordingly, in addition to all other remedies available to the Company at law or in equity, upon a showing by the Company that I have violated or am about to violate the terms of this Agreement, I hereby consent to the entry by a court of competent jurisdiction of an injunction or declaratory judgment enforcing the terms of 

  7

   

  

   

  this Agreement, including without limitation preventing disclosure or further disclosure by me of Proprietary Information.

  6.8	If any one or more provisions of this Agreement shall for any reason be held to be excessively broad as to time, duration, geographical scope, activity or subject, it shall be construed, by limiting and reducing it, so as to be enforceable to the extent compatible with the applicable law as it shall then appear.

   

  8

   

  

   

  I HAVE READ ALL OF THE PROVISIONS OF THIS AGREEMENT AND I UNDERSTAND, AND AGREE TO, EACH OF SUCH PROVISIONS, EFFECTIVE AS OF THE DATE FIRST ENTERED ABOVE.

   

  Accepted and Agreed:

  				
	Talkspace Inc. 
	 
	 
	Jennifer Fulk

	/s/ Oren Frank
	 
	 
	 /s/ Jennifer Fulk

	Oren Frank-CEO 
	 
	 
	 

	Date: July 2, 2021  
	 
	 
	Date: June 28, 2021

   

  9

   

  

   

  SCHEDULE A

   

  1.	I have an agreement with Eli Lilly to refrain from using Eli Lilly trade secrets or other confidential information.

   

  10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00331-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00331-of-00352.parquet"}]]